We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible

By HospiMedica International staff writers
Posted on 01 Dec 2023

Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued reliance on centralized laboratory diagnostics. More...

Now, a significant advancement has been achieved in diagnostic technology with the development of a 'lab on a chip' that can be created through 3D printing in just half an hour. This innovation holds the potential to make rapid, on-site testing widely accessible.

As part of a recent study, researchers at McGill University (Montreal, QC, Canada) have pioneered the development of capillaric chips, which essentially serve as miniaturized laboratories. In contrast to other computer microprocessors, these chips are designed for single use and do not need an external power source; they operate efficiently using just a paper strip. Their functionality is based on capillary action, the natural process that enables liquid to spontaneously move into an absorbent material, like a paper towel absorbing a spill on a table. Remarkably, these chips can be tailored through 3D printing for a variety of tests, including the quantification of COVID-19 antibodies.

This advancement brings the concept of 3D-printed home diagnostics closer to practical application, though challenges like obtaining regulatory approvals and securing the necessary testing materials still exist. The research team is committed to enhancing the accessibility of this technology, focusing on adapting it for use with more affordable 3D printers. innovation aims to accelerate diagnostic processes, improve patient care, and usher in a new era of convenient and accessible testing options.

“Traditional diagnostics require peripherals, while ours can circumvent them. Our diagnostics are a bit what the cell phone was to traditional desktop computers that required a separate monitor, keyboard and power supply to operate,” explained Prof. David Juncker, Chair of the Department of Biomedical Engineering at McGill and senior author on the study. “This advancement has the capacity to empower individuals, researchers, and industries to explore new possibilities and applications in a more cost-effective and user-friendly manner. This innovation also holds the potential to eventually empower health professionals with the ability to rapidly create tailored solutions for specific needs right at the point-of-care.”

Related Links:
McGill University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.